Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation

Transplant International

Volumn 24, Issue 8, 2011, Pages

  Biglarnia, Ali Reza ^a   Nilsson, Bo ^a   Nilsson, Thomas ^a   Von Zur Mühlen, Bengt ^a   Wagner, Michael ^a   Berne, Christian ^a   Wanders, Alkwin ^a   Magnusson, Anders ^a   Tufveson, Gunnar ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

ABO incompatible pancreas and kidney transplantation; accommodation; complement activation; Eculizumab

Indexed keywords

BASILIXIMAB; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3D; ECULIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CASE REPORT; COMPLEMENT ACTIVATION; FLOW CYTOMETRY; HISTOLOGY; HUMAN; IMMUNE DEFICIENCY; IMMUNOPHENOTYPING; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY PANCREAS TRANSPLANTATION; MALE; NEPHELOMETRY; PANCREAS FUNCTION; PHENOTYPE; PRIORITY JOURNAL;

ABO BLOOD-GROUP SYSTEM; ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; BLOOD GROUP INCOMPATIBILITY; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; RENAL INSUFFICIENCY;

EID: 79960120521     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2011.01290.x     Document Type: Article

References (17)

1. Gruessner AC, Sutherland DE, Gruessner RW,. Pancreas transplantation in the United States: a review. Curr Opin Organ Transplant 2010; 15: 93.
2. Kumlien G, Wilpert J, Safwenberg J, Tyden G,. Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers. Transplantation 2007; 84: S17.
3. Nilsson Ekdahl K, Nilsson B, Pekna M, Nilsson UR,. Generation of iC3 at the interface between blood and gas. Scand J Immunol 1992; 35: 85.
4. Nurnberger W, Bhakdi S,. Plasma C3d/C3 quotient as a parameter for in vivo complement activation. J Immunol Methods 1984; 74: 87.
5. Ekdahl KN, Norberg D, Bengtsson AA, Sturfelt G, Nilsson UR, Nilsson B,. Use of serum or buffer-changed EDTA-plasma in a rapid, inexpensive, and easy-to-perform hemolytic complement assay for differential diagnosis of systemic lupus erythematosus and monitoring of patients with the disease. Clin Vaccine Immunol 2007; 14: 549.
6. Nilsson UR, Nilsson B,. Simplified assays of hemolytic activity of the classical and alternative complement pathways. J Immunol Methods 1984; 72: 49.
7. Chatelet V, Fremeaux-Bacchi V, Lobbedez T, Ficheux M, Hurault de Ligny B,. Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome. Am J Transplant 2009; 9: 2644.
8. Sacks S, Zhou W,. The effect of locally synthesised complement on acute renal allograft rejection. J Mol Med 2003; 81: 404.
9. Marsh JE, Farmer CK, Jurcevic S, Wang Y, Carroll MC, Sacks SH,. The allogeneic T and B cell response is strongly dependent on complement components C3 and C4. Transplantation 2001; 72: 1310.
10. Pratt JR, Harmer AW, Levin J, Sacks SH,. Influence of complement on the allospecific antibody response to a primary vascularized organ graft. Eur J Immunol 1997; 27: 2848.
11. Pratt JR, Abe K, Miyazaki M, Zhou W, Sacks SH,. In situ localization of C3 synthesis in experimental acute renal allograft rejection. Am J Pathol 2000; 157: 825.
12. Riechmann L, Clark M, Waldmann H, Winter G,. Reshaping human antibodies for therapy. Nature 1988; 332: 323.
13. Thomas TC, Rollins SA, Rother RP, et al. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol Immunol 1996; 33: 1389.
14. Tyden G, Donauer J, Wadstrom J, et al. Implementation of a protocol for ABO-incompatible kidney transplantation - a three-center experience with 60 consecutive transplantations. Transplantation 2007; 83: 1153.
15. Takahashi K,. A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transplant. 2005; 19 (Suppl. 14): 76.
16. Cai J,. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009). Clin Transpl 2009; 83.
17. Kenmochi T, Asano T, Maruyama M, et al. Living donor pancreas transplantation in Japan. J Hepatobiliary Pancreat Sci 2010; 17: 101.